Graeme J. Moyle

Corporate Officer/Principal en Chelsea & Westminster Hospital .

60 años

Health Technology

Consumer Services

Cargos activos de Graeme J. Moyle

Empresas	Cargo	Inicio	Fin
Chelsea & Westminster Hospital	Corporate Officer/Principal	01/01/1994	-

Empresas	Cargo	Inicio	Fin
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.	Director/Miembro de la Junta	23/06/2014	-
	Independent Dir/Board Member	23/06/2014	-

University of Adelaide

Doctorate Degree

Internacional

Operativa

Director/Board Member	1
Independent Dir/Board Member	1
Doctorate Degree	1

Sectorial

Health Technology	2
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	2
Tobira Therapeutics, Inc. /Old/ Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.	Health Technology
Chelsea & Westminster Hospital

Empresas privadas

Health Technology

Chelsea & Westminster Hospital